TuHURA (HURA) Company Cash on Hand

HURA (TuHURA Biosciences) - company brandmark

TuHURA Biosciences, Inc. (HURA) cash on hand reflects liquidity dynamics, where the parameter is 0.00, correlating with the potential to develop high-margin drugs for the global market. The business foundation is based on creating personalized vaccines against resistant tumors. However, current clinical trial and R&D expenditures create a significant financial burden, keeping indicators at a stagnation plateau.

HURA - TuHURA Biosciences, Inc. Company Cash Funds over the range 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for tuhurabio.com (HURA)

Basic company analysis:TuHURA Biosciences, Inc.
Signature product of TuHURA Biosciences, Inc.

Conservative capital demands absolute liquidity transparency to assess business viability. This indicator measures the volume of free cash flow, determining the issuer's ability to fund operations without resorting to costly external loans. For TuHURA Biosciences, Inc. (HURA), this reserve is critical for financing expensive clinical trials of anti-cancer vaccines and protecting intellectual property. The trend of cash on the balance sheet reflects the company's current runway before reaching the next R&D milestones.

Competitors of TuHURA Biosciences, Inc.

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds